-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhitong Finance App News, Kanghong Pharmaceutical (002773.SZ) issued an announcement. Recently, the company's subsidiary Chengdu Kanghong Biotechnology Co., Ltd. (“Kanghong Biology”) received the KHN923 injection “Drug Clinical Trial Approval Notice” issued by the State Drug Administration. The drug's indication: Alzheimer's disease.
Share
Listen to the news
Zhitong Finance App News, Kanghong Pharmaceutical (002773.SZ) issued an announcement. Recently, the company's subsidiary Chengdu Kanghong Biotechnology Co., Ltd. (“Kanghong Biology”) received the KHN923 injection “Drug Clinical Trial Approval Notice” issued by the State Drug Administration. The drug's indication: Alzheimer's disease.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending